DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

7.54 -0.26 (-3.33%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

OREX $7.54 -3.33%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.74
Previous Close $7.80
Daily Range $7.45 - $7.82
52-Week Range $3.11 - $9.37
Market Cap $932.9M
P/E Ratio -24.38
Dividend (Yield) $0.00 (0.0%)
Volume 2,501,151
Average Daily Volume 4,913,523
Current FY EPS -$0.68




Drug Makers

Orexigen Therapeutics, Inc. (OREX) Description

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website:

News & Commentary Rss Feed

3 Promising Healthcare Stocks Under $10

Healthcare stocks with plenty of potential -- and low share prices

Don't Write Off Arena As Yet

7 Trends Drug Investors Should Know

Vivus Sales Remain Flat - Stock Trend Not Good

Arena's 15,000 Scripts Set Pace Vs. Competitors

The Best Stock to Invest in Obesity Drugs

Making money helping people shed the pounds.

Arena's Partner Eisai Is Slashing Jobs - What Investors Need To Consider

Novo Nordisk Quietly Becoming Big Player In Obesity Space

Arena - New Patent Extends Belviq Exclusivity And Adds Long-Term Value

Vivus: Qsymia Sales Dip In Weight Loss Season - Company Cutting Costs

See More OREX News...

OREX's Top Competitors

OREX $7.54 (-3.33%)
Current stock: OREX
GILD $101.38 (-1.90%)
Current stock: GILD
CELG $113.47 (-2.48%)
Current stock: CELG
AMGN $163.58 (-1.97%)
Current stock: AMGN